stalled for 9 weeks at 12.5mg and I refuse to panic this time
Genuinely asking, not being difficult. Everyone in c/tirzepatide repeats that biopsy is important. I believe it, but I have never seen anyone show why, and when I search I get 17 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true because…
This is correct. Do not generalise from tirzepatide.
Disagree. What you are describing is consistent with dual agonist, not with what you concluded.
the GLP-1/glucagon dual is glucagon, different from GIP/GLP-1
phase 14 data is interesting, phase 35 will be different
MASH claims need the trial and the biopsy endpoint